Quantcast
Channel: PR Newswire:
People Here Also Viewed:
Viewing all articles
Browse latest Browse all 51452

EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer

0
0
HUNTSVILLE, Ala., March 19, 2013 /PRNewswire/ -- EGEN, Inc. today announced that it has recently initiated a Phase I clinical trial of its novel immunotherapy agent, EGEN-001, in combination with PEGylated liposomal Doxorubicin or Lipodox for the treatment of recurrent ovarian...

Viewing all articles
Browse latest Browse all 51452

Latest Images

Trending Articles





Latest Images